Get started
Award

M01 RR00827

Funded outputs count: 35
Funder award ID: M01 RR00827
OpenAlex ID: G6073674831
Metabolomic Signatures of Inflammation in Chronic Kidney Disease
2026 · Teresa K. Chen, Aditya L. Surapaneni, et al. · Kidney Medicine
PDF
Editorial: Reading the cholate—A new gateway to portal hypertension and oesophageal varices: Authors' reply
2024 · Tarek Hassanein, Andrew P. Keaveny, et al. · Alimentary Pharmacology & Therapeutics · 4
Liver function and portal‐systemic shunting quantified by the oral cholate challenge test and risk for large oesophageal varices
2024 · Tarek Hassanein, Andrew P. Keaveny, et al. · Alimentary Pharmacology & Therapeutics · 22
PDF
Associations of Baseline and Longitudinal Serum Uromodulin With Kidney Failure and Mortality: Results From the African American Study of Kidney Disease and Hypertension (AASK) Trial
2023 · Teresa K. Chen, Michelle M. Estrella, et al. · American Journal of Kidney Diseases · 16
PDF
Orthostatic Hypotension and Symptoms in the AASK Trial
2018 · Stephen P Juraschek, Edgar R Miller, et al. · American Journal of Hypertension · 19
PDF
Metoprolol Increases Uric Acid and Risk of Gout in African Americans With Chronic Kidney Disease Attributed to Hypertension
2017 · Stephen P Juraschek, Lawrence J Appel, et al. · American Journal of Hypertension · 26
PDF
Effect of Intensive Blood Pressure Control on Cardiovascular Remodeling in Hypertensive Patients with Nephrosclerosis
2013 · Otelio Randall, John Kwagyan, et al. · International Journal of Nephrology · 4
PDF
Serum Vitamin D Levels Are Not Predictive of the Progression of Chronic Liver Disease in Hepatitis C Patients with Advanced Fibrosis
2012 · Kathleen E. Corey, Hui Zheng, et al. · PLoS ONE · 39
PDF
Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: Results from the hepatitis C antiviral long-term treatment against cirrhosis trial
2011 · Gregory T. Everson, Mitchell L. Shiffman, et al. · Hepatology · 78
PDF
An IL28B Genotype-Based Clinical Prediction Model for Treatment of Chronic Hepatitis C
2011 · Thomas R. O'Brien, James E. Everhart, et al. · PLoS ONE · 29
Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C
2011 · Anna S. Lok, James E. Everhart, et al. · Hepatology · 84
PDF
Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon
2011 · Adrian M. Di Bisceglie, Anne M. Stoddard, et al. · Hepatology · 58
PDF
Intensive Blood-Pressure Control in Hypertensive Chronic Kidney Disease
2010 · Barry I Freedman, John R Sedor · New England Journal of Medicine · 23
Intensive Blood-Pressure Control in Hypertensive Chronic Kidney Disease
2010 · Lawrence J. Appel, Jackson T. Wright, et al. · New England Journal of Medicine · 719
PDF
Outcome of Sustained Virological Responders With Histologically Advanced Chronic Hepatitis C†,‡,§,¶
2010 · Timothy R. Morgan, Marc G. Ghany, et al. · Hepatology · 479
PDF
Complication Rate of Percutaneous Liver Biopsies Among Persons With Advanced Chronic Liver Disease in the HALT-C Trial
2010 · Leonard B. Seeff, Gregory T. Everson, et al. · Clinical Gastroenterology and Hepatology · 471
PDF
Changes in quality of life and sexual health are associated with low‐dose peginterferon therapy and disease progression in patients with chronic hepatitis C
2010 · K. K. SNOW, H. L. BONKOVSKY, et al. · Alimentary Pharmacology & Therapeutics · 23
PDF
Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C # ∥ ‡
2009 · Neal D. Freedman, James E. Everhart, et al. · Hepatology · 178
PDF
Faculty Opinions recommendation of Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.
2009 · Richard Sampliner · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
PDF
Evolution of hepatic steatosis in patients with advanced hepatitis C
2009 · Anna S. Lok, James E. Everhart, et al. · Hepatology · 56
PDF
Variants in interferon‐alpha pathway genes and response to pegylated interferon‐Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long‐term treatment against cirrhosis trial†‡
2009 · Tania Mara Welzel, Timothy R. Morgan, et al. · Hepatology · 80
PDF
Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease
2009 · D. Harnois · Yearbook of Gastroenterology · 1
Correlates of N-Terminal Prohormone Brain Natriuretic Peptides in African Americans with Hypertensive Chronic Kidney Disease: The African American Study of Kidney Disease and Hypertension
2008 · S. Yi, G. Contreras, et al. · American Journal of Nephrology · 8
PDF
Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease
2008 · Anna S. Lok, Leonard B. Seeff, et al. · Gastroenterology · 651
PDF
Interpretation of positive transcription-mediated amplification test results from polymerase chain reaction–negative samples obtained after treatment of chronic hepatitis C
2008 · Chihiro Morishima, Timothy R. Morgan, et al. · Hepatology · 26
PDF
Year
Topic